CELL SIGNALING TECHNOLOGY search Cell Signaling Technology KDR products
includes other brands or spellings
|
| ih | | Cell Signaling Technology, Inc KDR antibody was tested in immunohistochemistry by HPA (CAB004028) . |
| ip, wb | | Cell Signaling Technology rabbit polyclonal anti-VEGFR-2 and phospho-VEGFR-2 antibody was used in western blot and immunoprecipitation to detect VEGFR-2 and phospho-VEGFR-2 in serum-starved PAE cells expressing VEGFR-1 and VEGFR-2. |
| ip, wb | | Cell Signaling antibody directed against phosphorylated tyrosine 1175 in the VEGFR-2 (KDR) was used in immunoprecipitation to isolate VEGFR-2 from porcine aortic endothelial (PAE) cells and in western blot to detect the presence of VEGFR-2 in PAE cells. |
| ip, wb | | Cell Signaling Technology anti-VEGFR-2 antibody (55B11) was used in western blot and immunoprecipitation to study the regulation of the endothelial cell response to Ang-1 through stable interaction between alpha5beta1 integrin and Tie2 tyrosine kinase receptor. |
| wb | | Cell Signaling antiphosphorylated VEGFR2 (Tyr-996) monoclonal antibody was used in western blot to study VEGF-induced neuropilin-1 expression. |
SIGMA-ALDRICH search Sigma-Aldrich KDR products
includes other brands or spellings
|
| ih | | Sigma anti-Flk-1 antibody was used in immunohistochemistry to study the effect of adenoviral vector expressing hepatocyte growth factor on chronic left ventricular remodeling and dysfunction in mice. |
SANTA CRUZ BIOTECHNOLOGY search Santa Cruz Biotechnology KDR products
includes other brands or spellings
|
| block, ic | | Santa Cruz Biotechnology polyclonal rabbit anti-VEGFR2 antibody was used in human Kaposi's sarcoma cells (KS cells) and in immunocytochemistry, blocking expriments to study the molecular mechanisms through which HIV-1-Tat protein inhibits vincristine-induced apoptosis of KS cells. |
| ih | | Santa Cruz rabbit anti-KDR antibody was used in immunohistochemistry to provide evidence that there is systemic production of VEGF and flt-1 in acute Kawasaki disease. |
| ih | | Santa Cruz Biotechnology mouse anti-human KDR monoclonal antibody was used in immunohistochemistry to detect KDR in morphologically normal human embryos. |
| ih | | Santa Cruz Biotechnology anti-VEGFR-2 antibody (SC504) was used in human HT29 tumors and in immunohistochemistry to study the role for the effect of receptor tyrosine kinase on lymphatic endothelial cells in the therapy of colon cancer lymph node metastasis. |
| ip, wb | | Santa Cruz Biotechnology antibody to KDR was used in immunoprecipitation to isolate KDR from human breast cancer cell lines BT474, MDA-MB-231, MDA-MB-435, and SK-BR3, and in western blot to detect KDR expression in human breast carcinoma MDA-MB-231 cells. |
| ip, wb | | Santa Cruz Biotechnology anti-VEGFR-2 antibody (SC-6251) was used in western blot and immunoprecipitation to study the regulation of the endothelial cell response to Ang-1 through stable interaction between alpha5beta1 integrin and Tie2 tyrosine kinase receptor. |
| wb | | Santa Cruz Biotechnology anti–Flk-1/KDR antibody was used in western blot to study the inhibitory effect of the angiotensin II type 2 receptor on VEGF-induced migration and in vitro tube formation of human endothelial cells. |
| wb | | Santa Cruz Biotechnology rabbit polyclonal anti-VEGF-R2 antibody was used in western blot to detect VEGF-R2 in VEC null cells. |
| wb | | Santa Cruz Biotechnology anti-human VEGFR-2 antibody was used in human foreskin tissue and in western blot to study the characteristic gene expression profile of human lymphatic microvascular Ecs. |
| wb | | SCBT anti-VEGFR2 antibody was used in western blot to investigate the regulatoin of VEGFR2/KDR by KLF2. |
| wb | | Santa Cruz Biotechnology anti-VEGFR-2 antibody was used in western blot to study the negative regulation of angiogenesis by HEX. |
R & D SYSTEMS search R & D Systems KDR products
includes other brands or spellings
|
| wb | | R & D Systems anti-human VEGFR-2 antibody was used in human foreskin tissue and in western blot to study the characteristic gene expression profile of human lymphatic microvascular Ecs. |
EMD BIOSCIENCES search EMD Biosciences KDR products
includes other brands or spellings
|
| ih | | Oncogene anti-phospho-VEGFR-2 antibody was used in human HT29 tumors and in immunohistochemistry to study the role for the effect of receptor tyrosine kinase on lymphatic endothelial cells in the therapy of colon cancer lymph node metastasis. |
MILLIPORE search Millipore KDR products
includes other brands or spellings
|
| wb | | Chemicon anti-VEGFR2 monoclonal antibody was used in western blot to study VEGF-induced neuropilin-1 expression. |
INVITROGEN search Invitrogen KDR products
includes other brands or spellings
|
| wb | | BIOSOURCE International anti-phospho-Tyr1057/1059 VEGFR-2 antibody was used in western blot to detect Tyr1057/1059 VEGFR-2 in serum-starved PAE cells expressing chimeric VEGFR-2 and N1054/CKR stimulated with CSF-1. |
Articles Reviewed |
| 1. Hideyasu Oh et al. Selective induction of neuropilin-1 by vascular endothelial growth factor (VEGF): a mechanism contributing to VEGF-induced angiogenesis. 2002 |
| 2. Kumi Yasukawa et al. Systemic production of vascular endothelial growth factor and fms-like tyrosine kinase-1 receptor in acute Kawasaki disease. 2002 |
| 3. Maria Grazia Lampugnani et al. VE-cadherin regulates endothelial actin activating Rac and increasing membrane association of Tiam. 2002 |
| 4. Maria Chiara Deregibus et al. HIV-1-Tat protein activates phosphatidylinositol 3-kinase/ AKT-dependent survival pathways in Kaposi's sarcoma cells. 2002 |
| 5. Simona Podgrabinska et al. Molecular characterization of lymphatic endothelial cells. 2002 |
| 6. Tomowaki Nakagawa et al. HEX acts as a negative regulator of angiogenesis by modulating the expression of angiogenesis-related gene in endothelial cells in vitro. 2003 |
| 7. Yiwen Li et al. Postinfarction treatment with an adenoviral vector expressing hepatocyte growth factor relieves chronic left ventricular remodeling and dysfunction in mice. 2003 |
| 8. Ralf Benndorf et al. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells. 2003 |
| 9. KarĂŻn Gogat et al. VEGF and KDR gene expression during human embryonic and fetal eye development. 2004 |
| 10. Kristina Holmqvist et al. The adaptor protein shb binds to tyrosine 1175 in vascular endothelial growth factor (VEGF) receptor-2 and regulates VEGF-dependent cellular migration. 2004 |
| 11. Sophia Ran et al. The vascular-ablative agent VEGF(121)/rGel inhibits pulmonary metastases of MDA-MB-231 breast tumors. 2005 |
| 12. Resham Bhattacharya et al. Inhibition of vascular permeability factor/vascular endothelial growth factor-mediated angiogenesis by the Kruppel-like factor KLF2. 2005 |
| 13. Ilaria Cascone et al. Stable interaction between alpha5beta1 integrin and Tie2 tyrosine kinase receptor regulates endothelial cell response to Ang-1. 2005 |
| 14. Rosana D Meyer et al. A single amino acid substitution in the activation loop defines the decoy characteristic of VEGFR-1/FLT-1. 2006 |
| 15. Anja Persson et al. A human protein atlas based on antibody proteomics. 2006 |
| 16. Robert B Rebhun et al. Targeting receptor tyrosine kinase on lymphatic endothelial cells for the therapy of colon cancer lymph node metastasis. 2006 |